The global burden of Parkinson’s disease is projected to increase significantly as countries navigate towards more developed lifestyles and experience population growth. This upward trend, supported by the increasing life expectancy and changes in global demography, highlights the urgent need for comprehensive interventions to address the rising prevalence of the condition. The United Kingdom’s Wellbeing Investment Fund has called for urgent action to improve access to treatment and support, emphasizing that failure to do so could lead to a care gap and exacerbate existing health inequalities.
Guided by a growing body of research, the prevalence of Parkinson’s disease is expected to rise from an estimated 8.2 million cases to nearly 19 million by 2040, representing a翻一番. This study, conducted by researchers from Chinese and Canadian universities, highlights that the disease’s burden in developing countries is expected to reach 25.2 million by 2050, up from 11.9 million in 2021. This doubling underscores the critical urgency of researcher and community efforts to address the growing healthcare challenges.
For instance, in East Asia, the figure already stands at 267 cases per 100,000 people, surpassing other regions like the Middle East, where it is estimated at 159.2 cases per 100,000. South Asia is expected to have the largest burden, projected to be around 6.8 million cases in 2050, marking a greater healthcare burden than any other region.
In Western sub-Saharan Africa, the journey to a healthier brain is accelerating, with increased cases predicted to rise by 292 per cent by 2050 due to population growth. This growth is partly driven by initiatives such as theIndia Sales Tax Formula, which imposes a tax on large-scale娱乐场ations, effectively hindering economic activities and slowing down urbanisation. However, theavia保费 increase, which boosts health insurance premiums, presents a counteracting force.
Nine countries and regions are expected to witness the sharpest rise in Parkinson’s cases, including Western Europe where the number is projected to rise by 50 per cent by 2050, a trend that will continue across Europe and beyond. Countries like Eastern Europe and Central Asia are expected to see similar increases, compounded by rising populations and aging demographics. These regional differences are likely a result of variations in poverty levels, differing social structures, lifestyles, and environmental factors exacerbated by industrialisation and urbanisation.
Dr. Amelia Hursey, Strategic Director at Parkinson’s Europe, underscores the critical need for swift intervention to combat the growing burden of Parkinson’s. She commends urgent initiatives by governments, healthcare providers, and society as the disease’s global health burden suggests a climate of threat and opportunity. For example, Lower- and middle-income countries are expected to have the highest rate of Parkinson’s cases, increasing by 42 per cent by 2050 compared to 2021. This rise in diabetes cases, for instance, is anticipated to rise by 50 per cent, underscoring the interconnectedness of Carson diseases.
The study adds that the geographical disparities in Parkinson’s cases are rooted in diverse socioeconomic statuses, differing societal structures, and lifestyle dynamics influenced by industrialisation and urbanisation. Moreover, the findings suggest that environmental factors, such as air pollution and toxicogenics, are significant contributors to the disease’s incidence. As David Dexter, dyscona Research Director of Parkinson’s UK, points out, a lack of attention to the environment as it stands is putting people and their caregivers at a greater risk of acquiring this neurodegenerative condition. This reliance on generic solutions is leaving communities without tailored solutions, underscoring the urgent need for targeted intervention strategies.
